Single rituximab dose as treatment for membranoproliferative glomerulonephritis relapse after kidney transplant

Nefrologia (Engl Ed). 2021 Sep-Oct;41(5):601-603. doi: 10.1016/j.nefroe.2021.11.003. Epub 2021 Nov 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Glomerulonephritis, Membranoproliferative* / drug therapy
  • Humans
  • Kidney Transplantation*
  • Plasmapheresis
  • Recurrence
  • Rituximab / therapeutic use

Substances

  • Rituximab